Data / Research funding / Texas / Methodist Hospital Research Institute
Methodist Hospital Research Institute: 158 NIH awards ($194.8M) and 5 NSF awards ($1M), fiscal years 2021 to 2026
Methodist Hospital Research Institute in Houston, TX is funded under 158 NIH awards ($194.8M) and 5 NSF awards ($1M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- XJUCJAYJWYV1
- State
- Texas
Awards
163 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $7,195,907 | August 1, 2020 | July 31, 2026 | ARIAS, CESAR AUGUSTO | reporter.nih.gov |
| The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression | NIH | National Cancer Institute | 2023 to 2025 | $5,126,849 | September 22, 2022 | August 31, 2027 | CHAN, KEITH SYSON | reporter.nih.gov |
| Novel Stem Cell Immunotherapy for MDR-Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,800,190 | June 4, 2021 | May 31, 2026 | JAGANNATH, CHINNASWAMY | reporter.nih.gov |
| Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,459,174 | June 1, 2022 | May 31, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Systematic modeling and prediction of cell-type-specific and spatiotemporal crosstalk pathways in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $3,953,570 | May 15, 2021 | April 30, 2027 | WONG, STEPHEN TC | reporter.nih.gov |
| Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,096,729 | September 12, 2022 | May 31, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Validation of a novel 3D culture platform for TNBC treatment selection | NIH | National Cancer Institute | 2022 to 2025 | $3,027,149 | September 20, 2022 | August 31, 2027 | YUN, KYUSON | reporter.nih.gov |
| Sudden Death Risk Assessment and Mechanistic Insights in Arrhythmic Mitral Valve Prolapse Using Cardiac MRI and Circulating Proteomic Biomarkers | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,960,139 | September 5, 2024 | June 30, 2029 | SHAH, DIPAN J. | reporter.nih.gov |
| Molecular Mechanism of Virulence Regulation in Streptococcus Pyogenes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,818,660 | June 7, 2021 | May 31, 2027 | KUMARASWAMI, MUTHIAH | reporter.nih.gov |
| Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,778,087 | July 1, 2022 | April 30, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Regulation of innate immunity by self-adjuvated MRNA vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,710,680 | August 12, 2025 | May 31, 2029 | JAGANNATH, CHINNASWAMY | reporter.nih.gov |
| Harnessing Neuroplasticity of Postural Sensorimotor Networks Using Non-Invasive Spinal Neuromodulation to Maximize Functional Recovery After Spinal Cord Injury | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,544,362 | December 1, 2021 | August 31, 2027 | SAYENKO, DIMITRY | reporter.nih.gov |
| Sirtuin -Dependent Regulation of Tuberculosis and HIV Interactions in Macrophages | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,534,348 | August 1, 2024 | July 31, 2029 | JAGANNATH, CHINNASWAMY | reporter.nih.gov |
| Outcome-Driven Approach to Minimize the Risks of Facial Distortion Following CMF Surgery | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,500,835 | May 1, 2013 | July 31, 2027 | GATENO, JAIME | reporter.nih.gov |
| Supplementary funding for U01NS104326 Clinical Trial Readiness for SCA1 and SCA3 (“READISCA”) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,483,066 | June 1, 2022 | December 31, 2023 | ASHIZAWA, TETSUO | reporter.nih.gov |
| Long-acting multi prevention implant for 2-year contraception and HIV PrEP | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,464,240 | April 1, 2023 | March 31, 2028 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Targeting the HIV-1 Reservoir in Myeloid Cells | NIH | National Institute of Mental Health | 2021 to 2025 | $2,418,195 | July 6, 2021 | May 31, 2027 | WANG, JIN | reporter.nih.gov |
| Spatial single-cell profiling to identify tumor-immune-bone niche features in HER2-low bone metastasis in response to T-DXd treatment. | NIH | National Cancer Institute | 2021 to 2024 | $2,412,165 | September 15, 2020 | August 31, 2025 | WONG, STEPHEN TC | reporter.nih.gov |
| Control of dysfunctional Tregs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,407,966 | February 1, 2014 | January 31, 2027 | LI, XIAN CHANG | reporter.nih.gov |
| Deep Learning Based Pharmacokinetic Model for Vancomycin | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,398,639 | September 21, 2023 | July 31, 2028 | NIGO, MASAYUKI | reporter.nih.gov |
| Cardiac Autonomic Activation In Atrial Fibrillation Triggers And Substrate | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,392,913 | April 1, 2023 | March 31, 2028 | VALDERRABANO, MIGUEL | reporter.nih.gov |
| VENOUS: A translational study of enterococcal bacteremia | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,305,203 | June 17, 2020 | May 31, 2026 | ARIAS, CESAR AUGUSTO | reporter.nih.gov |
| XBP1 Inhibition and STING activation for the treatment of cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,273,099 | April 8, 2022 | March 31, 2027 | HU, CHIH-CHI ANDREW | reporter.nih.gov |
| Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells | NIH | National Cancer Institute | 2021 to 2024 | $2,261,569 | February 15, 2020 | January 31, 2026 | LIU, XUEWU | reporter.nih.gov |
| Human Atherogenesis with Underlying Dysfunctional HDL-Free Cholesterol | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,250,059 | April 4, 2023 | February 28, 2027 | POWNALL, HENRY J. | reporter.nih.gov |
| S100A4 mediated immune suppression in GBM | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,162,990 | April 1, 2021 | December 31, 2026 | YUN, KYUSON | reporter.nih.gov |
| Reversal of Heart Failure: Role of Vascular Recovery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,132,634 | July 15, 2020 | September 30, 2024 | COOKE, JOHN P | reporter.nih.gov |
| Studies of a new checkpoint regulator in the control of intestinal inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,018,750 | June 7, 2021 | May 31, 2027 | ZHANG, ZHIQIANG | reporter.nih.gov |
| Clinical Impact of the Cefazolin Inoculum Effect | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,970,877 | June 1, 2025 | May 31, 2028 | ARIAS, CESAR AUGUSTO | reporter.nih.gov |
| Nanoparticle delivery of miRNA-based therapeutics to overcome clinical challenges in triple negative breast cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,969,673 | March 4, 2021 | February 28, 2027 | WANG, ZHIHUI | reporter.nih.gov |
| Convergent AI for Precise Breast Cancer Risk Assessment | NIH | National Cancer Institute | 2021 to 2024 | $1,967,056 | June 1, 2020 | May 31, 2025 | WONG, STEPHEN TC | reporter.nih.gov |
| Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy | NIH | National Institute on Aging | 2023 to 2025 | $1,947,918 | January 1, 2023 | December 31, 2026 | FARIDAR, ALIREZA | reporter.nih.gov |
| Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC) | NIH | National Cancer Institute | 2023 to 2025 | $1,910,419 | July 8, 2023 | June 30, 2028 | CHANG, JENNY C-N | reporter.nih.gov |
| Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches | NIH | National Cancer Institute | 2023 to 2025 | $1,906,818 | September 30, 2013 | April 30, 2026 | CHAN, KEITH SYSON | reporter.nih.gov |
| Understanding the mechanisms that regulate cytoplasmic capping and defining its contributions to post-transcriptional gene regulation | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,857,693 | August 15, 2020 | November 30, 2025 | KISS, DANIEL LOUIS | reporter.nih.gov |
| Systematic identification of astrocyte-tumor crosstalk regulating brain metastatic tumors | NIH | National Cancer Institute | 2021 to 2024 | $1,848,227 | February 15, 2020 | January 31, 2025 | WONG, STEPHEN TC | reporter.nih.gov |
| Regulation of Cell Death in HIV Reservoirs | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,778,945 | March 1, 2023 | February 29, 2028 | WANG, JIN | reporter.nih.gov |
| Relationship of the Human Astrocyte Matrisome with Synaptic Networks | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,761,143 | September 23, 2022 | July 31, 2027 | KRENCIK, ROBERT CONRAD | reporter.nih.gov |
| Induction of autosis to overcome resistance in adoptive cell therapy for solid tumors | NIH | National Cancer Institute | 2023 to 2025 | $1,691,813 | April 1, 2023 | March 31, 2028 | LU, YONG | reporter.nih.gov |
| A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC) | NIH | National Cancer Institute | 2022 to 2024 | $1,622,400 | June 10, 2022 | May 31, 2027 | CHANG, JENNY C-N | reporter.nih.gov |
| Targeting ER stress response in B-cell chronic lymphocytic leukemia | NIH | National Cancer Institute | 2021 to 2025 | $1,620,598 | September 17, 2013 | March 31, 2030 | HU, CHIH-CHI ANDREW | reporter.nih.gov |
| Mechanisms driving cardiac dysfunction in Autosomal Dominant Polycystic Kidney Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,615,000 | May 15, 2022 | April 30, 2027 | ALTAMIRANO, FRANCISCO | reporter.nih.gov |
| Molecular mechanism of streptococcal adaptation to host nutritional defenses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,609,624 | February 25, 2020 | January 31, 2027 | KUMARASWAMI, MUTHIAH | reporter.nih.gov |
| Systems-wide analysis of oxidative stress-responsive m6A epitranscriptome | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $1,609,232 | June 15, 2020 | March 31, 2026 | WENG, YI-LAN | reporter.nih.gov |
| “Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response” | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,569,424 | September 19, 2023 | August 31, 2028 | ROSTOMILY, ROBERT C | reporter.nih.gov |
| The Unique Roles of Tumor-Specific Th9 Cells for Solid Tumor Eradication | NIH | National Cancer Institute | 2022 to 2025 | $1,565,541 | March 1, 2021 | February 28, 2026 | LU, YONG | reporter.nih.gov |
| Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy | NIH | National Cancer Institute | 2022 to 2025 | $1,533,120 | January 1, 2021 | August 31, 2026 | LU, YONG | reporter.nih.gov |
| Targeting tumor repopulation and the immune microenvironment to overcome chemoresistance | NIH | National Cancer Institute | 2022 to 2025 | $1,532,628 | August 1, 2021 | July 31, 2026 | CHAN, KEITH SYSON | reporter.nih.gov |
| Advancing Endovascular PAD Treatment: Overcoming Critical Knowledge Gaps with MRI-histology | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,453,551 | July 1, 2024 | April 30, 2029 | ROY, TRISHA | reporter.nih.gov |
| Mechanisms of STING in malignant progression and therapy of CLL. | NIH | National Cancer Institute | 2023 to 2025 | $1,451,820 | February 1, 2023 | January 31, 2028 | HU, CHIH-CHI ANDREW | reporter.nih.gov |
| Role of lipid metabolism in CD8+ T cell ferroptosis | NIH | National Cancer Institute | 2023 to 2025 | $1,429,382 | September 19, 2023 | August 31, 2028 | YI, QING | reporter.nih.gov |
| Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells | NIH | National Cancer Institute | 2023 to 2025 | $1,395,982 | August 1, 2023 | July 31, 2028 | YI, QING | reporter.nih.gov |
| VENOUS ETHANOL ABLATION IN ISCHEMIC VENTRICULAR TACHYCARDIA- VELVET TRIAL | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,382,174 | May 1, 2023 | August 31, 2028 | VALDERRABANO, MIGUEL | reporter.nih.gov |
| Transfer Application - R01 CA223804 - Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,381,694 | June 7, 2018 | July 31, 2024 | YOU, MING | reporter.nih.gov |
| Systematic Alzheimer's disease drug repositioning (SMART) based on bioinformatics-guided phenotype screening and image-omics | NIH | National Institute on Aging | 2021 to 2022 | $1,379,286 | September 15, 2018 | May 31, 2024 | WONG, STEPHEN TC | reporter.nih.gov |
| Mechanism of Intratumoral Transport of Particulate Drugs | NIH | National Cancer Institute | 2021 to 2023 | $1,378,947 | June 15, 2018 | August 31, 2025 | CHEN, SHU-HSIA | reporter.nih.gov |
| Spinal Neuromodulation to Promote Physiologic and Molecular Plasticity in theInjured Spinal Cord | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,370,280 | September 20, 2023 | August 31, 2028 | HORNER, PHILIP J | reporter.nih.gov |
| Modulation of innate immune cells to create transplant tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,367,750 | March 1, 2011 | May 31, 2029 | LI, XIAN CHANG | reporter.nih.gov |
| Mechanisms of JAG1-mediated immune suppression in the pancreatic cancer microenvironment | NIH | National Cancer Institute | 2024 to 2025 | $1,344,898 | July 1, 2024 | June 30, 2026 | ZHOU, LAN | reporter.nih.gov |
| Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis | NIH | National Cancer Institute | 2024 to 2025 | $1,270,578 | February 2, 2024 | January 31, 2029 | YOU, MING | reporter.nih.gov |
| Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion | NIH | National Cancer Institute | 2021 to 2023 | $1,259,518 | August 1, 2019 | July 31, 2025 | YI, QING | reporter.nih.gov |
| Modulation of chromatin dynamics to promote transplant survival | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,254,850 | December 6, 2023 | October 31, 2028 | LI, XIAN CHANG | reporter.nih.gov |
| Microbiota-targeted approaches to resolve dysbiosis-induced AD neuropathology following brain injury. | NIH | National Institute on Aging | 2023 to 2024 | $1,254,408 | September 15, 2023 | August 31, 2025 | VILLAPOL, SONIA | reporter.nih.gov |
| Proteomics based mapping of cardiac extracellular matrix to define sex and age-dependent changes. | NIH | National Institute on Aging | 2024 to 2025 | $1,239,850 | August 1, 2023 | April 30, 2028 | CIESLIK, KATARZYNA A. | reporter.nih.gov |
| Novel gene delivery to modulate the tumor microenvironment and antigen-specific antitumor immunity | NIH | National Cancer Institute | 2024 to 2025 | $1,221,566 | June 1, 2024 | May 31, 2029 | CHEN, SHU-HSIA | reporter.nih.gov |
| Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,211,250 | December 1, 2019 | November 30, 2024 | POWNALL, HENRY J. | reporter.nih.gov |
| Metabolism and Epigenetic Regulation are Couples in Transdifferentiation and Vascular Regeneration | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,211,250 | September 1, 2024 | August 31, 2028 | LAI, LI | reporter.nih.gov |
| Landscapes for Cell State Transition Leveraging by Single-Cell Multi-Omics | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,211,217 | September 1, 2023 | August 31, 2028 | WANG, GUANGYU | reporter.nih.gov |
| P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy | NIH | National Cancer Institute | 2021 to 2024 | $1,203,668 | September 1, 2020 | May 31, 2025 | LU, YONG | reporter.nih.gov |
| Decoupling acute toxicities and antitumor efficacy in adoptive cell therapy | NIH | National Cancer Institute | 2024 to 2025 | $1,194,123 | May 1, 2024 | April 30, 2029 | LU, YONG | reporter.nih.gov |
| Chemoprevention of lung cancer by targeting lonidamine to mitochondria | NIH | National Cancer Institute | 2021 to 2023 | $1,190,559 | April 15, 2019 | August 31, 2025 | YOU, MING | reporter.nih.gov |
| Training in Neural Control of organ Degeneration and Regeneration (NeuralCODR) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,161,930 | July 1, 2022 | June 30, 2027 | HORNER, PHILIP J | reporter.nih.gov |
| 4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,116,244 | August 1, 2023 | July 31, 2030 | GHOBRIAL, RAFIK MARK | reporter.nih.gov |
| Novel Targeted Therapeutics for Breast Cancer | NIH | National Cancer Institute | 2022 to 2024 | $1,090,776 | July 1, 2020 | June 30, 2025 | OZPOLAT, BULENT | reporter.nih.gov |
| Quantitation of nutrient metabolism in brain tumor patients using advanced 13C isotopomer technology | NIH | National Cancer Institute | 2023 to 2025 | $1,088,422 | September 1, 2023 | August 31, 2028 | PICHUMANI, KUMAR | reporter.nih.gov |
| A randomized, sham-controlled clinical trial evaluating individualized neuromodulation of cortical regions involved in neurogenic overactive bladder in Multiple Sclerosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,039,129 | January 24, 2023 | December 31, 2027 | KHAVARI, ROSE | reporter.nih.gov |
| Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors | NIH | National Cancer Institute | 2024 to 2025 | $979,714 | January 1, 2024 | December 31, 2028 | YI, QING | reporter.nih.gov |
| Exploring the role of estrogen receptor beta in progression and metastasis ofInflammatory breast cancer | NIH | National Cancer Institute | 2022 to 2024 | $953,897 | December 1, 2019 | November 30, 2025 | THOMAS, CHRISTOFOROS | reporter.nih.gov |
| The Impact of Sleep on Network Coding and Perceptual Performance | NIH | National Eye Institute | 2024 to 2025 | $950,638 | August 1, 2016 | December 31, 2026 | DRAGOI, VALENTIN | reporter.nih.gov |
| Exploring the role and potential of anti-viral drugs to sensitize cancer cells to chemotherapy | NIH | National Cancer Institute | 2024 to 2025 | $944,710 | June 1, 2024 | May 31, 2029 | YI, QING | reporter.nih.gov |
| The LiaFSR system and antimicrobial peptide resistance in enterococci | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $943,570 | May 18, 2018 | June 30, 2024 | ARIAS, CESAR AUGUSTO | reporter.nih.gov |
| Transforming Curiosity into Donation: Validating a Risk Prediction Index to Detect and Prevent Drop-Out in Potential Living Kidney Donors who are Racial/Ethnic Minorities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $900,098 | September 1, 2023 | May 31, 2028 | WATERMAN, AMY DOGGETTE | reporter.nih.gov |
| A Neonatal Monkey Model of Tuberculosis Vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $893,080 | June 1, 2019 | May 31, 2023 | JAGANNATH, CHINNASWAMY | reporter.nih.gov |
| LILRB modulates tumor microenvironment and promotes tumor progression | NIH | National Cancer Institute | 2021 to 2022 | $850,533 | April 1, 2016 | November 30, 2024 | CHEN, SHU-HSIA | reporter.nih.gov |
| Center for the Dissemination of Ultra-Long-Acting Antiretroviral Release Technology: DART Resource Program | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $846,258 | August 20, 2025 | July 31, 2030 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Natural Phenolic Compounds against Oral Candidiasis (OC) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $817,417 | August 9, 2024 | July 31, 2029 | MYLONAKIS, ELEFTHERIOS | reporter.nih.gov |
| T cell fate decisions and transplant outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $807,500 | January 10, 2018 | December 31, 2023 | LI, XIAN CHANG | reporter.nih.gov |
| IRF4-dependent T-cell effector programs in governing transplant outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $807,500 | May 1, 2018 | January 11, 2024 | CHEN, WENHAO | reporter.nih.gov |
| Pathogenesis in Segmental Demyelination | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $804,961 | June 1, 2023 | May 31, 2028 | HU, BO | reporter.nih.gov |
| Functional roles of mTOR in tumor persistence | NIH | National Cancer Institute | 2024 to 2025 | $802,174 | April 4, 2024 | March 31, 2029 | LI, YULIN | reporter.nih.gov |
| Age-related TDP-43 neuropathology: using disease-driving mechanisms to guide classification | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $790,914 | September 15, 2020 | March 31, 2026 | CYKOWSKI, MATTHEW DANIEL | reporter.nih.gov |
| Myelin Junction Therapy in Peripheral Neuropathies | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $769,539 | March 15, 2020 | December 31, 2025 | LI, JUN | reporter.nih.gov |
| Alternative polyadenylation in Right Ventricular Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2024 | $760,708 | September 25, 2024 | September 24, 2025 | AMIRTHALINGAM THANDAVARAYAN, RAJARAJAN | reporter.nih.gov |
| Multi-omic integrative analysis of shared and distinct inflammation networks across neurodegenerative disorders | NIH | National Institute on Aging | 2024 | $760,207 | September 30, 2024 | August 31, 2025 | FARIDAR, ALIREZA | reporter.nih.gov |
| Exploring functional complexes and disease networks within human RNA-binding protein interactomes | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $747,792 | August 1, 2019 | June 30, 2025 | BRANNAN, KRISTOPHER | reporter.nih.gov |
| VENOUS ETHANOL ABLATION IN ISCHEMIC VENTRICULAR TACHYCARDIA- VELVET TRIAL | NIH | National Heart, Lung, and Blood Institute | 2023 | $738,259 | May 1, 2023 | April 30, 2024 | VALDERRABANO, MIGUEL | reporter.nih.gov |
| Self-assembled multifunctional aptamer-complex biomaterial for precision medicine | NIH | National Cancer Institute | 2021 to 2022 | $731,474 | January 15, 2018 | June 30, 2024 | ZU, YOULI | reporter.nih.gov |
| Role of Cdk9 in the Pathogenesis of Pulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2025 | $705,334 | January 1, 2025 | November 30, 2028 | HAUDENSCHILD, DOMINIK R | reporter.nih.gov |
| Gut microbiome communication with the bone marrow regulates intestinal inflammation. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $696,020 | March 16, 2020 | February 28, 2027 | BURGESS, STACEY L | reporter.nih.gov |
| Cortical encoding of unconscious visual information and its impact on behavior | NIH | National Eye Institute | 2023 to 2024 | $691,500 | September 30, 2020 | June 30, 2025 | DRAGOI, VALENTIN | reporter.nih.gov |
| Antimicrobial Resistance Training Program in the Texas Medical Center (AMR-TPT) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $689,345 | July 1, 2024 | June 30, 2029 | ARIAS, CESAR AUGUSTO | reporter.nih.gov |
| DeepStroke+: An Advanced Mobile AI Diagnostic Tool for Fast and Precise Detection of Acute Strokes in Mobile Stroke Units, Emergency Rooms, and Telestroke Triage | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $619,969 | February 1, 2025 | January 31, 2030 | WONG, STEPHEN TC | reporter.nih.gov |
| Advancing Thyroid Cancer Diagnostics with AI-enhanced Multimodal Optical Histopathology | NIH | National Cancer Institute | 2025 | $593,383 | January 1, 2025 | December 31, 2029 | WONG, STEPHEN TC | reporter.nih.gov |
| Targeting Notch2 in Hematopoietic Cell Therapy | NIH | National Heart, Lung, and Blood Institute | 2022 | $590,982 | December 15, 2011 | June 30, 2025 | ZHOU, LAN | reporter.nih.gov |
| CAR T Cells for Advanced Thyroid Cancer | NIH | National Cancer Institute | 2024 | $588,696 | February 2, 2024 | March 31, 2026 | JIN, MOONSOO M. | reporter.nih.gov |
| The immunosuppressive function of secretory IgM in tumor-bearing mice | NIH | National Cancer Institute | 2021 to 2023 | $582,552 | June 1, 2021 | May 31, 2024 | TANG, CHIH-HANG ANTHONY | reporter.nih.gov |
| Learning-Based Approach for Personalized Craniomaxillofacial Surgical Planning | NIH | National Institute of Dental & Craniofacial Research | 2021 | $574,725 | July 1, 2017 | June 30, 2025 | GATENO, JAIME | reporter.nih.gov |
| OSTEO: Engineering a predictive digital twin of bone metastasis | NSF | Chemical, Bioengineering, Environmental, & Transport Systems | 2026 | $549,705 | September 15, 2026 | August 31, 2029 | Stefano Casarin | nsf.gov |
| Chemoprevention of Lung Cancer with Mitochondria-Targeted Honokiol | NIH | National Cancer Institute | 2021 | $523,684 | March 1, 2017 | August 31, 2023 | YOU, MING | reporter.nih.gov |
| POR and Training Program on Multidrug-Resistant Organisms | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $506,264 | May 25, 2016 | June 30, 2026 | ARIAS, CESAR AUGUSTO | reporter.nih.gov |
| Genetic mechanism of conserved ancestral haplotype in SCA10 | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $477,396 | February 1, 2019 | June 30, 2024 | ASHIZAWA, TETSUO | reporter.nih.gov |
| Inhibition of Oral Tumorigenesis by Antitumor B | NIH | National Cancer Institute | 2022 | $471,422 | December 8, 2016 | May 31, 2025 | YOU, MING | reporter.nih.gov |
| Emergence of TonB-dependent receptor mediated cefiderocol resistance among multidrug-resistant (MDR) Pseudomonas aeruginosa clinical isolates. | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $467,482 | January 20, 2023 | December 31, 2025 | MILLER, WILLIAM R | reporter.nih.gov |
| Neural coding of natural stimuli in freely moving macaque | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $466,031 | July 15, 2022 | June 30, 2025 | DRAGOI, VALENTIN | reporter.nih.gov |
| A multiplexed high-throughput platform to report pharmacologic alteration of cancer stem cell membrane potential and cell cycle state | NIH | National Cancer Institute | 2024 to 2025 | $463,811 | April 1, 2024 | March 31, 2027 | ROSTOMILY, ROBERT C | reporter.nih.gov |
| Modulation of tumor inflammatory factor for immune therapy | NIH | National Cancer Institute | 2021 | $463,463 | September 22, 2017 | August 31, 2025 | CHEN, SHU-HSIA | reporter.nih.gov |
| Photoacoustic Imaging to Guide Catheter Ablation of Cardiac Arrhythmias | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $452,660 | April 18, 2022 | March 31, 2025 | MATHURIA, NILESH | reporter.nih.gov |
| A versatile reporter for visualization of myelin plasticity in the genetically modified rat | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $444,125 | July 1, 2021 | December 31, 2023 | HORNER, PHILIP J | reporter.nih.gov |
| Human Astrocyte-Based Nanovesicles to Target Neuroinflammation in Alzheimer's Disease | NIH | National Institute on Aging | 2022 | $444,125 | February 15, 2022 | January 31, 2024 | KRENCIK, ROBERT CONRAD | reporter.nih.gov |
| Molecular basis of decreased susceptibility to beta-lactam antibiotics in Streptococcus pyogenes | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $444,125 | March 24, 2022 | February 28, 2025 | MUSSER, JAMES MALLORY | reporter.nih.gov |
| Methods and devices to assist and improve cerebrospinal fluid drainage | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $444,125 | July 1, 2022 | June 30, 2025 | BRITZ, GAVIN WAYNE | reporter.nih.gov |
| Intranasal Delivery of Telomerase Reverse Transcriptase mRNA for Therapy ofTraumatic Brain Injury | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $444,125 | September 26, 2022 | August 31, 2024 | GODIN, BIANA | reporter.nih.gov |
| Patterned optogenetic neuromodulation to reprogram glioma stem cells | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $444,125 | January 9, 2024 | December 31, 2025 | ROSTOMILY, ROBERT C | reporter.nih.gov |
| Streptococcal virulence regulation by a novel intercellular signaling pathway | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $444,125 | August 8, 2025 | July 31, 2027 | KUMARASWAMI, MUTHIAH | reporter.nih.gov |
| Novel Determinants of Streptococcus Pyogenes Virulence and Protective Immunity in the Primate Oropharynx: A Genome-wide Strategy | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $439,989 | June 1, 2021 | May 31, 2022 | MUSSER, JAMES MALLORY | reporter.nih.gov |
| Enhancing CAR-T cell therapy through theranostic targeted radionuclide therapy | NIH | National Cancer Institute | 2024 | $415,260 | June 1, 2024 | May 31, 2026 | YANG, YANPING | reporter.nih.gov |
| Targeting metabolic stress response to improve CAR-T cell efficacy. | NIH | National Cancer Institute | 2024 | $415,257 | July 1, 2024 | June 30, 2026 | MIN, IRENE M. | reporter.nih.gov |
| Development of a pre-clinical syngeneic pig glioma model for research and translational studies | NIH | National Cancer Institute | 2024 | $415,257 | September 1, 2024 | August 31, 2026 | ROSTOMILY, ROBERT C | reporter.nih.gov |
| Hes1-loss promotes dysregulation of epithelial homeostasis and inflammation in a serrated adenocarcinoma model | NIH | National Cancer Institute | 2022 | $406,858 | June 24, 2023 | May 31, 2025 | ZHOU, LAN | reporter.nih.gov |
| Role of S-nitrosylation in Transdifferentiation | NIH | National Heart, Lung, and Blood Institute | 2021 | $403,750 | April 1, 2018 | November 30, 2022 | COOKE, JOHN P | reporter.nih.gov |
| Metabolism and Epigenetic Regulation are Couples in Transdifferentiation and Vascular Regeneration | NIH | National Heart, Lung, and Blood Institute | 2023 | $403,750 | September 1, 2023 | August 31, 2024 | LAI, LI | reporter.nih.gov |
| Development of new Pt-based ROS storm inducing polymers with tumor specific toxicity | NIH | National Cancer Institute | 2025 | $403,485 | September 1, 2025 | August 31, 2027 | MAI, JUNHUA | reporter.nih.gov |
| Artificial intelligence-integrated mechanistic modeling for rational design of nanoparticles to improve organ targeting and safety | NIH | National Institute of Biomedical Imaging and Bioengineering | 2024 | $391,588 | September 9, 2024 | August 31, 2028 | DOGRA, PRASHANT | reporter.nih.gov |
| Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome | NIH | National Cancer Institute | 2022 to 2023 | $390,035 | January 10, 2022 | December 31, 2024 | THOMAS, CHRISTOFOROS | reporter.nih.gov |
| Pathogen and patient determinants of Candida gut colonization in critically ill patients | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $388,072 | June 1, 2024 | May 31, 2029 | ADELMAN, MAX WIENER | reporter.nih.gov |
| A Novel Role for MAGI1 in regulating non-canonical LATS signaling and atherosclerotic plaque formation | NIH | National Heart, Lung, and Blood Institute | 2021 | $380,587 | January 1, 2017 | February 28, 2023 | LE, NHAT-TU | reporter.nih.gov |
| In situ and real-time readout of nuclear mechanotransduction via single cell mechanics and site-specific fluorescence reporting | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $375,092 | September 15, 2023 | August 31, 2025 | HAUDENSCHILD, DOMINIK R | reporter.nih.gov |
| Role of MIF in myeloma bone homing and drug response | NIH | National Cancer Institute | 2021 | $369,431 | January 1, 2017 | December 31, 2022 | YI, QING | reporter.nih.gov |
| The Germ Cell Gene TDRD1 as a Novel Prostate Cancer Biomarker | NIH | National Cancer Institute | 2021 | $369,431 | March 15, 2017 | August 31, 2023 | HE, BIN | reporter.nih.gov |
| African trypanosome parasites: a new tool to unveil potential immunological strategies to target CLL | NIH | National Cancer Institute | 2021 | $360,852 | May 3, 2021 | April 30, 2024 | HU, CHIH-CHI ANDREW | reporter.nih.gov |
| Role of YxdJK and DAK in the Enterococcal Envelope Stress Response | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $356,910 | May 3, 2018 | April 30, 2023 | MILLER, WILLIAM R | reporter.nih.gov |
| A nanofluidic platform for tunable drug delivery | NIH | National Institute of General Medical Sciences | 2021 | $338,921 | April 15, 2018 | January 31, 2023 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Targeting macrophages to sensitize myeloma to immune checkpoint blockade | NIH | National Cancer Institute | 2021 | $335,113 | March 15, 2017 | February 28, 2023 | YI, QING | reporter.nih.gov |
| Virtual Reality-Based Cognitive Intervention For The Prevention of Delirium & Cognitive Impairment In Geriatric Surgical Patients | NIH | National Institute on Aging | 2022 to 2023 | $323,000 | September 1, 2022 | August 31, 2024 | FAISAL, HINA | reporter.nih.gov |
| Impact of Irreversible T Cell Dysfunction on Transplant Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $323,000 | May 1, 2018 | December 31, 2024 | CHEN, WENHAO | reporter.nih.gov |
| LDHA-dependent T-cell effector programs in heart transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $300,000 | August 7, 2025 | July 31, 2026 | CHEN, WENHAO | reporter.nih.gov |
| Mechanisms of Resistance and Clinical Outcomes of non-Carbapenemase Producing Carbapenem-Resistant Klebsiella pneumoniae Infections | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $259,461 | March 1, 2025 | February 28, 2027 | MILLER, WILLIAM R | reporter.nih.gov |
| Collaborative Research: FW-HTF-RL: Collaborative Remote Physical Examination: Transforming Medical and Nursing Practice | NSF | Civil, Mechanical, & Manufacturing Innovation | 2023 | $248,310 | September 1, 2023 | August 31, 2027 | Ericka P Greene | nsf.gov |
| Virtual Reality-Based Cognitive Stimulation Games for Enhancing Attention and Preventing Delirium in Older Surgical Patients with Cognitive Impairment: A Randomized Controlled Pilot Trial | NIH | National Institute on Aging | 2025 | $242,840 | September 2, 2025 | May 31, 2030 | FAISAL, HINA | reporter.nih.gov |
| Novel translational strategies to combat group B streptococcus infections | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $242,250 | November 12, 2024 | October 31, 2026 | KUMARASWAMI, MUTHIAH | reporter.nih.gov |
| High-resolution mapping of the human brainstem during continence and micturition: noninvasive in vivo 7 Tesla fMRI study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $241,577 | January 18, 2021 | December 31, 2023 | KHAVARI, ROSE | reporter.nih.gov |
| Collaborative Research [FW-HTF-RM]: The Future of Nurse Training: Robotic Teaching Assistant Systems for Nursing Instructors | NSF | Education Capacity Building & Transformation Section | 2023 | $171,997 | November 1, 2023 | October 31, 2027 | Shannan K Hamlin | nsf.gov |
| Development of a stable mRNA prophylactic vaccine against SARS-CoV-2 omicron variant | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $161,500 | August 18, 2025 | July 31, 2027 | MAI, JUNHUA | reporter.nih.gov |
| MRI Biomarkers of Disease Progression in Inherited Neuropathies | NIH | National Center for Advancing Translational Sciences | 2022 | $153,458 | April 1, 2021 | March 31, 2024 | LI, JUN | reporter.nih.gov |
| Flow, Fatty Acid Biosynthesis, and Hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $150,000 | August 1, 2023 | July 31, 2024 | FANG, LONGHOU | reporter.nih.gov |
| Role of cortical connections to higher-order thalamic nuclei in visual decision-making | NIH | National Eye Institute | 2024 | $124,009 | September 1, 2023 | August 31, 2025 | ANDREI, ARIANA R | reporter.nih.gov |
| SUPRASPINAL TARGETS IN NEUROGENIC VOIDING DYSFUNCTION | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $100,210 | August 17, 2018 | July 31, 2022 | KHAVARI, ROSE | reporter.nih.gov |
| A new conditional TDPΔNLS knock-in mouse model generated using CRISPR/Cas9 technology to study the linkage of TDP-43 pathology to motor and cognitive defects in ALS, FTD and ADRD | NIH | National Institute on Aging | 2021 | $80,750 | April 15, 2020 | February 28, 2023 | HEGDE, MURALIDHAR L | reporter.nih.gov |
| Collaborative Research: FW-HTF-R: The Future of Robot-Assisted Nursing: Interactive AI Frameworks for Upskilling Nurses and Customizing Robot Assistance | NSF | Division Of Computer and Network Systems | 2022 | $28,238 | September 1, 2022 | August 31, 2024 | Shannan K Hamlin | nsf.gov |
| Patricia Levy Zusman International Workshop on Neuroregeneration (Zusman Workshop) | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $22,000 | December 15, 2022 | December 14, 2023 | HORNER, PHILIP J | reporter.nih.gov |
| Conference: 43rd Conference of Texas Statisticians | NSF | Division Of Mathematical Sciences | 2024 | $21,000 | June 15, 2024 | May 31, 2025 | Sunil Mathur | nsf.gov |
| 2025 Patrica Levy Zusman International Workshop on Neuroregeneration | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $14,000 | March 1, 2025 | February 28, 2026 | HORNER, PHILIP J | reporter.nih.gov |
| Neurogenic Bladder Research Group (NBRG) symposium: Partnering with Engineering in Neurogenic Bladder Research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $10,000 | August 21, 2024 | August 20, 2025 | KHAVARI, ROSE | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 1 | $549,705 |
| 2025 | 82 | $49,980,214 | 0 | $0 |
| 2024 | 94 | $51,834,048 | 1 | $21,000 |
| 2023 | 76 | $36,835,708 | 2 | $420,307 |
| 2022 | 65 | $32,638,282 | 1 | $28,238 |
| 2021 | 52 | $23,485,396 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 2 awards here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 36 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 36 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 36 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 36 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 36 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 36 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 36 awards here |
Topics of its NIH awards
- Cancer
- Genetics
- Biotechnology
- Neurosciences
- Clinical Research
- Rare Diseases
- Immunotherapy
- Bioengineering
- Translational Research
- Infectious Diseases
- Orphan Drug
- Brain Disorders
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.